| Serial Number | 98218314 |
| Word Mark | WUXIDARX |
| Filing Date | Wednesday, October 11, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 26, 2025 |
| Registration Number | 7922912 |
| Registration Date | Tuesday, August 26, 2025 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 20, 2024 |
| Goods and Services | Custom assembling of materials, namely, custom assembling of antibody drug conjugates and intermediates thereof for others; Custom manufacturing of pharmaceuticals; Custom manufacturing of drug conjugates; Customized production service of pharmaceuticals; Customized production service of biological preparations; Custom manufacturing of Antibody-drug Conjugates; Processing and treating of chemical reagents, namely, custom production of reagents for scientific or medical research use; Pharmaceutical processing, namely, processing of pharmaceutical materials for others being processing of medicinal plants and biological organisms; Processing of biomedical preparations for others being biomanufacturing for others in the nature of manufacturing of pharmaceuticals and vaccines using biological organisms in the manufacturing process; Processing of chemical materials for production of drug conjugates for others |
| Description of Mark | The mark consists of the word "WuXiDARx" with "WuXi" in black, the "D" is in green, the "A" is in blue with a partial crossbar in light blue that extends to the adjacent "R" in light blue followed by a small "x" in black, underneath "WuXiDARx" is a line in the colors light blue, orange, green, and the blue part of the line extends upward to form the "A". |
| Indication of Colors claimed | The color(s) black, green, blue, light blue, orange is/are claimed as a feature of the mark. |
| Goods and Services | Development of new products for others; pharmaceutical drug development service; Research and development of new products; Biochemical research and development; Custom design and development of chemical reagent antibodies and conjugate antibodies; Research and development in the field of pharmaceutical biomedicine and biotechnology, namely, research of antibodies, namely, conjugated antibodies; Biomedical research services; Development of pharmaceutical preparations and medicines; Research and development of Antibody-drug Conjugates; Research and development of drug conjugates |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 16, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | Tuesday, October 17, 2023 |
| First Use In Commerce Date | Tuesday, October 17, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 16, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, October 17, 2023 |
| First Use In Commerce Date | Tuesday, October 17, 2023 |
| Party Name | WUXI XDC SINGAPORE PRIVATE LIMITED |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | 100 AM SINGAPORE 079027 SG |
| Party Name | WUXI XDC SINGAPORE PRIVATE LIMITED |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | 100 AM SINGAPORE 079027 SG |
| Party Name | WUXI XDC SINGAPORE PRIVATE LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | 100 AM SINGAPORE 079027 SG |
| Event Date | Event Description |
| Saturday, October 14, 2023 | NEW APPLICATION ENTERED |
| Tuesday, October 17, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, May 29, 2024 | ASSIGNED TO EXAMINER |
| Monday, October 16, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 29, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 29, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 29, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, July 17, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 17, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 17, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 18, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 31, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 20, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 15, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, November 1, 2024 | USE AMENDMENT FILED |
| Friday, August 1, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Saturday, August 2, 2025 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, August 26, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 26, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Saturday, August 2, 2025 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, August 20, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, November 1, 2024 | TEAS STATEMENT OF USE RECEIVED |